FOX
59
2
CCI
25
4
ED
43
4
COP
30
5
ISRG
62
2
NSC
48
14
SLB
38
6
URBN
44
-3
K
53
6
ETN
53
3
WMB
51
3
CB
47
3
HUM
40
4
CPB
34
4
ECL
37
3
HIG
66
3
ITW
31
6
AIV
30
4
KMB
36
8
CL
53
3
FOX
59
2
CCI
25
4
ED
43
4
COP
30
5
ISRG
62
2
NSC
48
14
SLB
38
6
URBN
44
-3
K
53
6
ETN
53
3
WMB
51
3
CB
47
3
HUM
40
4
CPB
34
4
ECL
37
3
HIG
66
3
ITW
31
6
AIV
30
4
KMB
36
8
CL
53
3
Financhill
Back

Telix Pharmaceuticals 10K Form

Buy
58

TLPPF
Telix Pharmaceuticals

Last Price:
$16.61
Seasonality Move:
36.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TLPPF News And Ratings

See the #1 stock for the next 7 days that we like better than TLPPF

TLPPF Financial Statistics

Sales & Book Value

Annual Sales: $516.7M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.06
Price / Book: 15.73

Profitability

EPS (TTM): 0.09490
Net Income (TTM): $32.7M
Gross Margin: $336.2M
Return on Equity: 13.56%
Return on Assets: 4.54%

Telix Pharmaceuticals Earnings Forecast

Key Telix Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 7 years for TLPPF is 65.08%.
  • The Selling, General & Administrative Expenses for TLPPF have been equal to 29.73% of Gross Profit Margin.
  • The Research & Development expenses have been 24.85% of Revenue.
  • The Interest Expense is 73.10% of Operating Income.
  • The Net Earning history of TLPPF is 6.37% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Telix Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TLPPF
Website: telixpharma.com

Debt

Debt-to-Equity Ratio: 1
Current Ratio: 2.78
Quick Ratio: 2.63

Price-to-Earnings

Trailing P/E Ratio: 174.11
Forward P/E Ratio: 0

TLPPF Technical Analysis vs Fundamental Analysis

Buy
58
Telix Pharmaceuticals (TLPPF) is a Buy

Is Telix Pharmaceuticals a Buy or a Sell?